Susanne Brandl serves as the Global Patient Partnership Principal Director at Roche, leading initiatives in respiratory and infectious diseases since May 2023 and previously managing multiple aspects of global patient partnerships from January 2022 to May 2023. Brandl's extensive background includes consulting for diverse mandates, directing the Novo Nordisk Haemophilia Foundation to enhance access to quality healthcare across developing countries, and holding senior roles in health care strategy at Novo Nordisk. Educational qualifications span institutions such as Harvard Business School and MIT, along with significant training in business leadership, digital transformation, and sustainability. With a robust legal foundation and expertise in stakeholder engagement, Brandl has effectively influenced policy development and healthcare delivery on a global scale.
This person is not in any teams
This person is not in any offices
Roche
303 followers
Roche is the world's largest biotech company engaged in producing, branded drugs for the treatment of cancer and other diseases.